GLP-1 receptor agonists could protect elderly diabetes patients from osteoporosis, reveals research
A recent retrospective study published in the Frontiers in Endocrinology suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may significantly reduce the risk of osteoporosis in elderly diabetic patients. Type 2 diabetes has long been recognized as a hidden contributor to bone weakening, often leading to higher fracture rates and poor outcomes. However, this new research […]
